Advanced search
Publication Cover
Renal Failure Volume 40, 2018 - Issue 1
Submit an article Journal homepage
2,072
Views
4
CrossRef citations to date
0
Altmetric
Clinical Study

Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism

Keiichi OtsukaDepartment of Internal Medicine, Oshima Clinic, Saitama, Japan; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-4957-3830
ORCID Icon,
Yoichi OhnoDepartment of Nephrology, Saitama Medical School, Saitama, Japan
&
Joji OshimaDepartment of Internal Medicine, Oshima Clinic, Saitama, Japan;
Pages 38-42 | Received 28 Sep 2017, Accepted 16 Dec 2017, Published online: 04 Jan 2018

References

  • Llach F. Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited. Am J Kidney Dis. 1995;25:663–679.
  • Nemeth EF, Heaton WH, Miller M, et al. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther. 2004;308:627–635.
  • Sterrett JR, Strom J, Stummvoll HK, et al. Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism. Clin Nephrol. 2007;68(1):10–17.
  • Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20:981–996.
  • Kazama JJ, Kazama S, Koda R, et al. The risk of gallbladder stone formation is increased in patients with predialysis chronic kidney disease but not those undergoing chronic hemodialysis therapy. Nephron Clin Pract. 2009;111:c167–c172.
  • Hahm JS, Lee HL, Park JY, et al. Prevalence of gallstone disease in patients with end-stage renal disease treated with hemodialysis in Korea. Hepatogastroenterology. 2003;50:1792–1795.
  • Li Vecchi M, Cesare S, Soresi M, et al. Prevalence of biliary lithiasis in a Sicilian population of hemodialysis patients. Clin Nephrol. 2001;55:127–132.
  • Gençtoy G, Ayidağa S, Ergun T, et al. Increased frequency of gallbladder stone and related parameters in hemodialysis patients. Turk J Gastroenterol. 2014;25:54–58.
  • Campese VM. Autonomic nervous system dysfunction in uraemia. Nephrol Dial Transplant. 1990;5(Suppl 1):98–101.
  • Pauletzki J, Paumgartner G. Review article: defects in gall-bladder motor function – role in gallstone formation and recurrence. Aliment Pharmacol Ther. 2000;14(Suppl 2):32–34.
  • Barut I, Tarhan OR, Baykal B, et al. Higher incidence of cholelithiasis in chronic renal failure patients with secondary hyperparathyroidism undergoing peritoneal dialysis. Ren Fail. 2007;29:453–457.
  • Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980;1:1317–1320.
  • Broulik PD, Haas T, Adámek S. Analysis of 645 patients with primary hyperparathyroidism with special references to cholelithiasis. Intern Med. 2005;44:917–921.
  • Bhadada SK, Bhansali A, Shah VN, et al. High prevalence of cholelithiasis in primary hyperparathyroidism: a retrospective analysis of 120 cases. Indian J Gastroenterol. 2011;30:100–101.
  • Heaton KW, Braddon FE, Mountford RA, et al. Symptomatic and silent gall stones in the community. Gut. 1991;32:316–320.
  • Layer P, Hotz J, Sinewe S, et al. Bile secretion in acute and chronic hypercalcemia in the cat. Dig Dis Sci. 1986;31:188–192.
  • Ahrendt SA, Ahrendt GM, Pitt HA, et al. Hypercalcemia decreases bile flow and increases biliary calcium in the prairie dog. Surgery. 1995;117:435–442.
  • Mok LL, Nickols GA, Thompson JC, et al. Parathyroid hormone as a smooth muscle relaxant. Endocr Rev. 1989;10:420–436.
  • Ray JM, Squires PE, Curtis SB, et al. Expression of the calcium-sensing receptor on human antral gastrin cells in culture. J Clin Invest. 1997;99:2328–2333.
  • Ceglia L, Harris SS, Rasmussen HM, et al. Activation of the calcium sensing receptor stimulates gastrin and gastric acid secretion in healthy participants. Osteoporos Int. 2009;20:71–78.
  • Fukumoto K, Noguchi T, Toriie S, et al. The mechanism of upper-gastrointestinal complication after taking cinacalcet hydrochloride. J Jpn Soc Dial Ther. 2010;43:309–315.
  • Liou AP, Sei Y, Zhao X, et al. The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am J Physiol Gastrointest Liver Physiol. 2011;300:G538–G546.
  • Díez JJ, Miguel JL, Codoceo R, et al. Effects of cinacalcet on gastrointestinal hormone release in patients with secondary hyperparathyroidism undergoing dialysis. Nephrol Dial Transplant. 2008;23:1387–1395.
  • Holtermuller KH, Mallagelada JR, McCall JT, et al. Pancreatic, gallbladder, and gastric responses to intraduodenal calcium perfusion in man. Gastroenterology. 1976;70:693–696.
  • Mosonyi L, Irsy G, Tóth B. Oddi’s sphincter spasm in hypocalcaemia of dogs. Acta Physiol Acad Sci Hung. 1978;52:419–424.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.